Urinary Incontinence clinical trials at UCSD
1 research study open to eligible people
open to eligible females ages 21 years and up
The primary aim is to compare the effectiveness of intradetrusor injection of 100 unit injection of Botulinum toxin A to mid-urethral sling for change in MUI symptoms 6 months following treatment.
La Jolla, California and other locations
Our lead scientists for Urinary Incontinence research studies include Emily Lukacz, MD.